Neurotrophin-3 (NT-3) plays numerous important roles in the CNS
Introduction
Neurotrophin-3 (NT-3) is largely enriched and has multiple roles in the CNS (Huang and Reichardt, 2003) . It functions mainly through the TrkC, its high-affinity receptor with intrinsic receptor tyrosine kinase (RTK) activity . NT-3 also binds to two other high-affinity receptors, TrkA and TrkB, as well as a low-affinity receptor, p75
NTR . Activation of TrkC receptors can stimulate three classical signaling cascades, whose components include phospholipase C (PLC)-Ca 2ϩ , Ras-Raf-extracellular signalregulated kinase, and phosphatidylinositol 3 (PI 3 ) kinase-Akt (Huang and Reichardt, 2003) . Activation of these cascades is correlated with intracellular Ca 2ϩ ([Ca 2ϩ ] i ) changes (Xia et al., 1996; Furukawa and Mattson, 1998; Clapham, 2007) and implicated in the varied actions of NT-3, ranging from modulation of neuronal morphology (McAllister et al., 1997) , synaptic plasticity (Lohof et al., 1993; Yang et al., 2001) , neuronal survival (Schecterson and Bothwell, 1992) , and differentiation (Averbuch-Heller et al., 1994) , to neurotransmitter release (Bonni et al., 1999; Poo, 2001) . Furthermore, the [Ca 2ϩ ] i changes due to extracellular Ca 2ϩ influx are important for NT-3 to exert its physiological functions. For example, NT-3-induced Ca 2ϩ influx following TrkC activation is required for modulation of the excitatory GABAergic synaptic transmission (Gao and van den Pol, 1999) , differentiation of calbindin-D 28k -positive pyramidal neurons (Boukhaddaoui et al., 2001) , and activation of Ca 2ϩ -dependent K ϩ channels (Holm et al., 1997) . However, the mechanism that enables NT-3 to induce Ca 2ϩ influx remains largely unknown. The transient receptor potential canonical (TRPC) channels, a subfamily of nonselective cation channels, emerge as a new route responsible for [Ca 2ϩ ] i elevation when receptor tyrosine kinase (RTK) or G-protein-coupled receptors (GPCRs) are activated (Clapham, 2007) . The TRPC subfamily contains seven members (TRPC1-TRPC7). Based on amino acid similarities, the TRPCs are divided into three subgroups: (1) TRPC1; (2) TRPC3, TRPC6, and TRPC7; and (3) TRPC4 and TRPC5. Meanwhile, TRPC2 is classified as a human pseudogene. TRPC activation includes both receptor-operated and store-operated mechanisms. The stimulation of GPCRs or RTKs leads to PLC activation, which cleaves phosphatidylinositol 4,5-bisphosphate (PIP 2 ) to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP 3 ). DAG could directly activate TRPCs and IP 3 binds to IP 3 receptors, leading to store-operated TRPC activation. Unlike the relatively wide distribution of other TRPCs, the distribution of TRPC5 is mainly restricted to the CNS. However, the physiological agonist for TRPC5 in the CNS remains largely unknown.
It has been reported that brain-derived neurotrophic factor (BDNF) can activate TRPC3 and TRPC6 channels via the TrkB-PLC pathway (Li et al., 1999; Amaral and Pozzo-Miller, 2007; Jia et al., 2007) . Because NT-3 can also stimulate PLC, we hypothesized that NT-3 might induce Ca 2ϩ influx through TRPC channels. Indeed, the RTK is involved in the activation of nonselective cation channels formed by TRPC4 and TRPC5 independent of internal Ca 2ϩ stores in human embryonic kidney (HEK) 293 cells (Schaefer et al., 2000) . Furthermore, both NT-3 and TRPC5 are
Materials and Methods
Reagents and antibodies. Neurotrophin-3, neurotrophin-4, and brainderived neurotrophic factor were purchased from Millipore; TrkC-IgG from R&D Systems; K252a from Merck; Fura-2 AM and Mitotracker from Invitrogen; and nifedipine, SKF96365, and Hoechst33342 from Sigma-Aldrich. The 3-nitrocoumarin (3-NC) was a gift from R.T. Martegani (Milano-Bicocca University, Italy). The 7-OH-3-NC was synthesized according to the previous report and confirmed by mass spectrometry and nuclear magnetic resonance spectroscopy (Perrella et al., 1994; Ward et al., 2002) . All the other reagents were from Sangon Biotech unless otherwise specified.
We purchased anti-TRPC4, anti-TRPC5, and anti-TRPC6 antibodies from Alomone Labs; anti-HSP60 and anti-TrkC from R&D Systems (for immunostaining) and Santa Cruz Biotechnology (for immunoprecipitation); anti-TrkA, anti-PLC␥1, anti-CaMKIV, and anti-pan-CaMKII from Cell Signaling Technology; anti-TrkB from Becton Dickinson; anti-␣-tubulin and anti-CaMKII␣ from Sigma-Aldrich; anti-IP 3 R, antipCaMKI (Thr177), anti-pCaMKII␣ (Thr286), and anti-pCaMKIV (Thr196), anti-rabbit IgG, HRP-conjugated anti-goat IgG from Santa Cruz Biotechnology; anti-CaMKI␥ from Abcam; HRP-conjugated antimouse, rabbit IgG from GE Healthcare; and Alexa fluor 488, 546 conjugated anti-mouse, rabbit IgG from Invitrogen. Anti-TRPC3 was produced in our laboratory (Ding et al., 2010) .
Cell culture and transfection. Primary hippocampal neurons were isolated and cultured as described previously (Shi et al., 2004) . Briefly, the neurons were obtained by dissociating the hippocampus of embryonic day 18 Sprague Dawley rat (Shanghai Slack Laboratory Animal) brains of either sex, and seeded onto coverslips (No.1 Glass, Warner Instruments) coated with 50 g/ml poly-D-lysine (Sigma-Aldrich) at a density of 100,000 neurons per coverslip and cultured in Neurobasal A supplemented with B-27 and 0.5 mM glutamine (Invitrogen). All the rats were anesthetized and treated according to animal welfare guidelines of the Institute of Neuroscience, Chinese Academy of Sciences. The HEK293 cells were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Biochrom).
For Ca 2ϩ imaging assay and biochemical experiments, 4 ϫ 10 6 neurons were electroporated using Nucleofector Kit (Lonza Cologne) with 4 g of indicated siRNA or plasmids plus 1 g of Discosoma red (dsRed) as an indicator for the transfected neurons. Parts of the transfected neurons were seeded on the coverslips for Ca 2ϩ imaging and the rest of the transfected neurons were cultured for biochemical experiments. Additionally, 2 g of each indicated plasmid was transfected in HEK293 cells using lipofectamin 2000 (Invitrogen). DsRed was cotransfected with the plasmids at a ratio of 1:6 to indicate the transfected HEK293 cells. For the morphology experiments, we transfected neurons at 3-4 d in vitro (DIV) using Ca 2ϩ phosphate as reported previously (Ramos et al., 2007) . The yellow fluorescent protein (YFP) was used at the ratio of 1:5 (YFP/target plasmids) to indicate the transfected cells.
Immunoblotting. Total proteins extracted from male rat brain hippocampal tissues using the radioimmunoprecipitation assay (RIPA) buffer (in mM, 150 NaCl, 5 EDTA, 1% Triton X-100, 1 Na 3 VO 4 , 50 NaF, 1 PMSF, 1 aprotinin, 1 leupeptin, 5 DTT, protease inhibitors, and 10 Tris-Cl, pH 7.4) or total proteins extracted from cultured cells using SDS lysis buffer (2% SDS, 10% glycerol, 0.1 mM dithiothreitol, and 0.2 M Tris-HCl, pH 6.8) were Western-blotted with the indicated primary and secondary antibodies. Bound antibodies were detected by the enhanced chemiluminescence detection system (GE Healthcare). The band optical densities were quantified by ImageQuant software (GE Healthcare). The relative amount of proteins was determined by normalizing the densitometry value of interest bands to that of the internal loading control and the external control.
Immunostaining. The cultured neurons at 7 DIV were fixed with paraformaldehyde buffer (4% paraformaldehyde in 0.1 M phosphate buffer supplemented with 0.1% picric acid and 0.05% glutaraldehyde, pH 7.4) for 20 min and then permeabilized with 0.1% Triton X-100 for 2 min. After blocking in 10% goat serum, the interesting proteins were probed with the primary antibodies at 4°C overnight and with fluorescent secondary antibodies at room temperature for 50 min. For morphology assay, we stained the transfected neurons with the antibody against YFP to observe the details of neuronal branches. The fluorescent signals were examined using an A1R laser-scanning confocal microscope (Nikon).
Electrophysiology. Whole-cell currents were recorded using a MultiClamp patch 700A amplifier (Molecular Devices). Patch pipettes were made from borosilicate glass and had resistances of 5-7 M⍀ when filled with high-cesium intracellular solutions (in mM, 140 CsCl, 10 EGTA, 0.3 Mg 2 ATP, 0.3 CaCl 2 , and 10 HEPES, pH 7.25). Before recording, the cells were transferred into the normal extracellular solution (in mM, 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES, pH 7.4). Drugs were applied to cells by the eight-channel perfusion system (ALA Scientific Instruments). The flow rate was adjusted to 1-2 ml/min. Currents were filtered at 5 kHz, digitized using a Digidata 1322 Interface (Molecular Devices), and analyzed with pClamp 9.0 software (Molecular Devices). Experiments were performed at room temperature (22-24°C). Cells were recorded with a holding potential at Ϫ60 mV.
RNAi construct. The sequences (5Ј-3Ј) of siRNA synthesized to specifically target indicated rat genes by GenePharma were as follows: negative control sense: UUCUCCGAACGUGUCACGUTT; negative control antisense: ACGUGACACGUUCGGAGAATT; siTrkA_1402 sense: GGAG CAAAUUUGGGAUCAATT; siTrkA_1402 antisense: UUGAUCCCAAA UUUGCUCCTT; siTrkB_1766 sense: GGACGAGAGACAGAUUUCUTT; siTrkB_1766 antisense: AGAAAUCUGUCUCUCGUCCTT; siTrkC_1425 sense: GGUCCAAAUUUGGAAUGAATT; siTrkC_1425 antisense: UU-CAUUCCAAAUUUGGACCTT; siTRPC5_1686 sense: AACGCCUU CUCCACGCUCUUU; siTRPC5_1686 antisense: AAAGAGCGUGGAGA AGGCGUU; siTRPC6_2066 sense: CGGUGGUCAUCAACUACAATT; siTRPC6_2066 antisense: UUGUAGUUGAUGACCACCGTT.
Short hairpin RNA (shRNA) were designed and cloned into the pPRIME vector (Stegmeier et al., 2005) . The shRNA sequences (5Ј-3Ј) targeting rat TRPC5, TRPC6, or scramble were as follows: shTRPC5i: GCACTCTATGTGGCAGGACAT; shTRPC6i: CCTCTCCATATGG-TATGAGAA; scramble: TTCTCCGAACGTGTCACGAAG.
Immunoprecipitation. Whole brain lysates extracted from postnatal day 8 rats of either sex using the RIPA buffer were precipitated with 2 g of rabbit anti-TrkC antibody or rabbit IgG at 4°C overnight. Protein A beads (20 l, GE Healthcare) were then added to the supernatant and incubated at 4°C overnight. The samples were centrifuged to pellet the beads and washed three times using the RIPA buffer and resuspended using 2 ϫ SDS buffer for Western blotting.
Cytosolic Ca 2ϩ measurement. Changes in [Ca 2ϩ ] i concentration were measured using Fura-2-AM. Briefly, a total of 7 ϫ 10 4 primary cultured neurons were seeded on coverslips and at 6 -8 DIV incubated with 2 M Fura-2-AM at 37°C for 25 min. Cells were washed three times with normal extracellular solution (in mM, 120 NaCl, 6 KCl, 2 CaCl 2 , 2 MgCl 2 , 12 glucose, 12 sucrose, and 10 HEPES-free acid, pH 7.4) or with 0 Ca 2ϩ extracellular solution (in mM, 120 NaCl, 6 KCl, 2 MgCl 2 , 12 glucose, 5 EGTA, and 10 HEPES-free acid, pH 7.4) and imaged using a Eclipse Ti microscope (Nikon) with dual excitation wavelengths for Fura-2-AM at 340 and 380 nm and detection of fluorescent emission at 500 nm. For the Ca 2ϩ imaging in neurons with gene manipulation, only the neurons with red fluorescence were measured and included in calculations. For the experiment of reconstructing NT-3-induced Ca 2ϩ change in the heterologous expression system, only the cells with red fluorescence were measured. Also, to make sure the exogenously expressed TRPC5 channels were functional, only the cells responding to LaCl 3 in the groups of TRPC5 and TRPC5 plus TrkC were included in calculations. The ratios ( R) of the emission at 500 nm induced by 340 and 380 nm excitation were captured at 6 s intervals and presented. The ⌬R/R 0 was calculated as following: (RϪR 0 )/R 0 where R 0 was the mean value of R during the pretreatment time frame (baseline) in each experiment (Jia et al., 2007) . The ⌬R/R 0 area was defined as the cumulative area of the [Ca 2ϩ ] i elevation curve within the stimulating period, which indicated the changes of total amount of intercellular Ca 2ϩ within a given time.
Image analysis. Confocal images of the neurons were obtained using A1R laser-scanning confocal microscope (Nikon) with sequential acquisition settings at the resolution of 1024 ϫ 1024 pixels. Each image was a z-series of seven images at 1 m depth interval when 40ϫ oil objective was used. The z-series images were "flattened" into a single image using the maximal projection. Using Neurolucida software (MicroBrightField), the dendritic morphology was quantified in two ways: (1) total dendritic tip numbers and total dendritic length per neuron; and (2) Sholl analysis. Transfection experiments were performed in duplicate wells and all experiments were repeated at least three times. More than 10 neurons per group were obtained each time. The colocalizations between Trk and TRPC proteins were estimated using Fiji ImageJ JACoP (NIH) (Bolte and Cordelières, 2006) . To access colocalization, we used both Pearson's correlation coefficient (PCC) and Mander's overlap coefficient (MOC). PCC is a parameter used to quantify correlation across pixels of all intensities in each channel with a value close to 1 indicating reliable colocalization. MOC calculates the percentage of pixel intensities of the TRPC merged with Trk relative to the total intensities of TRPC, with 1 being high colocalization and 0 being low colocalization.
Statistics. Statistical analysis for protein levels, Ca 2ϩ imaging, and dendritic morphology was performed using a two-sided Student's t test. p Values Ͻ0.05 were considered statistically significant. Data were presented as mean Ϯ SEM.
Results

The expression pattern of TRPC5 was similar to that of TrkC
We first examined the expression of TRPC5 and Trks in the developing rat hippocampus by Western blot. The specificity of the commercial antibodies against TRPC5 and TRPC6 was examined and confirmed. The expression of TrkA started from the embryonic stage and decreased four weeks after birth. The expression of TrkB and TrkC was similar to that of TRPC6 and TRPC5, with a low level at early developmental stages and peak level between postnatal day 7 and 14, remaining high up to adult (Fig. 1A) . We then examined the subcellular localization of TrkB, TrkC, TRPC5, and TRPC6 by immunostaining on cultured hippocampal neurons. As shown in Figure 1 , B-D, both TrkC and TRPC5 were localized on the dendrites and soma, with most TRPC5 staining merged with TrkC staining (PCC, 0.856 Ϯ 0.009; MOC, 0.895 Ϯ 0.032). In contrast, most staining of TRPC6 merged well with that of TrkB (PCC, 0.882 Ϯ 0.014; MOC, 0.936 Ϯ 0.041), which is consistent with the previous report (Jia et al., 2007) . Together, TRPC5 and TrkC showed a similar developmental expression pattern in rat hippocampus and they had a subcellular colocalization in cultured hippocampal neurons. These results provide anatomic evidence to indicate a possible physiological relationship between TRPC5 channels and TrkC.
NT-3 induced Ca
2؉ influx sensitive to SKF96365 in cultured hippocampal neurons Using Ca 2ϩ imaging analysis, we then determined whether NT-3 could induce [Ca 2ϩ ] i changes in cultured hippocampal neurons (Fig. 2 A) . NT-3 induced a slow and small [Ca 2ϩ ] i elevation in neurons in a dose-dependent manner and the time of the delay to onset or the rising time of the [Ca 2ϩ ] i elevation was 1.326 Ϯ 0.190 min or 10.090 Ϯ 0.582 min, respectively (Fig. 2 B) . Further quantitative analysis in [Ca 2ϩ ] i by measuring the area under the [Ca 2ϩ ] i elevation curve within the treatment period revealed that NT-3 induced the [Ca 2ϩ ] i elevation with a threshold concentration of 25 ng/ml (10 ng/ml, 0.025 Ϯ 0.008; 25 ng/ml, 0.102 Ϯ 0.043; 50 ng/ml, 0.513 Ϯ 0.075 normalized to 100 ng/ml. Fig.  2C,D) . Because 50 ng/ml NT-3 was able to induce a repeatable [Ca 2ϩ ] i elevation, we performed the following experiments with ] i changes. I, Statistics of the normalized area of ⌬R/R 0 curve in G and H. Cultured hippocampal neurons were measured at 7-9 DIV. NT-3, 50 ng/ml unless otherwise specified. Data were presented as means Ϯ SEM from at least three independent experiments with Ͼ60 cells in each group. this concentration. We next used an NT-3 scavenger TrkC-IgG, a chimeric recombinant protein known to specifically neutralize NT-3 at an equimolar ratio (Shelton et al., 1995) , to determine the minimal concentration of NT-3 needed to evoke Ca 2ϩ signals. We estimated that 300 ng/ml TrkC-IgG was able to completely neutralize the action of 50 ng/ml NT-3. Indeed, as shown in Figure 2, Fig. 2G,I ) and suppressed by SKF96365, a nonspecific TRPC channel inhibitor (SKF, 0.179 Ϯ 0.041, p Ͻ 0.001 vs vehicle. Fig. 2 H, I ). Together, these results suggested that TRPC channels may be involved in the NT-3-induced Ca 2ϩ influx.
TRPC5 was required for NT-3-induced Ca 2؉ influx in the hippocampal neurons We next examined whether NT-3 stimulates TRPC5 to induce [Ca 2ϩ ] i elevation in the neurons transfected with constructs and dsRed to indicate the neurons analyzed (Fig. 3A) . As shown in Figure 3 , B and H, the NT-3-induced [Ca 2ϩ ] i change in the neurons transfected with a dominantnegative form of TRPC5 (dnTRPC5), in which three residues' mutations in the pore region were generated to inhibit its channel activity (Strübing et al., 2003) , was 34.56 Ϯ 11.76% of that in the neurons transfected with the control vector ( p ϭ 0.005 vs control). Moreover, expression in the neurons of a small interfering RNA against TRPC5 (siTRPC5), which downregulated TRPC5 without affecting TRPC4 or TRPC6 (Fig. 3C) , greatly inhibited NT-3-induced [Ca 2ϩ ] i elevation [si-TRPC5, 0.580 Ϯ 0.118, p ϭ 0.012 vs negative control siRNA (N.C.), Fig.  3C ,H]. In contrast, in the neurons transfected with dnTRPC6, in which three mutations in a pore region were made to block the channel activity (Hofmann et al., 2002) , ] i elevation was similar to that in the neurons transfected with control vectors (dn-TRPC6, 1.139 Ϯ 0.196, p ϭ 0.510 vs con- ] i elevation in theneuronstransfectedwith(F)controlvector(graydot),dnTRPC5(blackdot),ordnTRPC6(opensquares);(G)N.C.orsiTRPC6.H,Statistics of the normalized area of ⌬R/R 0 curve from B to G. *p Ͻ 0.05; **p Ͻ 0.01. I, Representative whole-cell recording traces with active or heat-inactivatedNT-3(HI-NT-3)intheneuronstransfectedwithcontrolvector(nϭ11)ordnTRPC5(nϭ12).Control(Ctrl),2.973Ϯ0.854 pA/pF; dnTRPC5, 0.269 Ϯ 0.116 pA/pF. NT-3, 100 ng/ml. J, Statistic results of the peak amplitude of the current shown in I. K, Representativecurrent-voltagecurvesofthecurrentsshowninI.AramppotentialholdingfromϪ90toϩ90mVwasappliedbeforeandafterNT-3 stimulationtoobtainpurifiedNT-3conductance.DatainCa 2ϩ imagingweremeansϮSEMfromatleastthreeindependentexperiments with Ͼ40 cells in each group. Cultured hippocampal neurons were electroporated with indicated siRNA or plasmids and measured at 7-9 DIV. For electrophysiology experiment, cultured hippocampal neurons were transfected with control vector or dnTRPC5 plasmids at 3 DIV and recorded at 7-9 DIV. ␣-Tubulin served as a loading control. NT-3 and NT-4, 50 ng/ml unless otherwise specified.
trol, Fig. 3 D, H ) . Similarly, expression in the neurons of a small interfering RNAi against TRPC6 (siTRPC6), which downregulated TRPC6 without affecting TRPC5 or TRPC3, did not affect the NT-3-induced [Ca 2ϩ ] i elevation (siTRPC6, 1.092 Ϯ 0.074, p ϭ 0.344 vs N.C., Fig. 3 E, H ) . Furthermore, dnTRPC5 did not affect the [Ca 2ϩ ] i elevation induced by NT-4, the receptor of which is TrkB (Ip et al., 1993) (dnTRPC5, 0.940 Ϯ 0.195 , p ϭ 0.788 vs control, Fig. 3 F, H ) , whereas dnTRPC6 (dnTRPC6, 0.243 Ϯ 0.074, p ϭ 0.009 vs control, Fig. 3 F, H ) To further verify that NT-3 indeed activates TRPC5, we performed whole-cell patch-clamp recording. In the control neurons, heat-inactivated NT-3 did not evoke a membrane current, whereas applying active NT-3 induced a small inward current (the peak current density was 2.973 Ϯ 0.854 pA/pF, n ϭ 11). In the neurons transfected with dnTRPC5, the current density was greatly suppressed (the peak current density was 0.269 Ϯ 0.116 pA/pF, n ϭ 12, p ϭ 0.010 vs control, Fig.  3 I, J ) . The current-voltage relationship analysis showed a double rectifying conductance with a reverse potential near 0 mV, which is a characteristic of the TRPClike current (Fig. 3K ) . Together, these results suggest that TRPC5 mediated the NT-3-induced [Ca 2ϩ ] i elevation in the hippocampal neurons.
TrkC receptors mediated the activation of TRPC5 by NT-3
To identify the receptor that mediates the activation of TRPC5 by NT-3, we examined the effect of K252a, an agent known as a nonspecific Trk receptor inhibitor, on [Ca 2ϩ ] i elevation induced by NT-3. As shown in Figure 4 , A and H, treatment with K252a greatly inhibited the [Ca 2ϩ ] i elevation (K252a, 0.260 Ϯ 0.069, p ϭ 0.009 vs vehicle), indicating that the highaffinity Trk receptors, but not P75 NTR , mediated NT-3-induced [Ca 2ϩ ] i elevation. To specify which Trk receptor mediated this process, we designed three siRNA molecules (siTrkA, siTrkB, and siTrkC) specifically against TrkA, TrkB, and TrkC (Fig. 4 B-D) . In the neurons transfected with either siTrkA or siTrkB, the NT-3-elevated [Ca 2ϩ ] i was not changed compared with that in the neurons transfected with negative control siRNA (N.C.) (siTrkA, 0.966 Ϯ 0.217, p ϭ 0.890 vs N.C.; siTrkB, 1.229 Ϯ 0.238, p ϭ 0.438 vs N.C., Fig. 4 B, C,H ) . In contrast, the NT-3-elevated [Ca 2ϩ ] i in the neurons transfected with siTrkC was reduced to 40.96 Ϯ 10.58% of that in the neurons transfected with negative control siRNA ( p ϭ 0.005 vs N.C., Fig. 4 D, H ) To provide further evidence that TRPC5 was indeed activated by NT-3 through TrkC, we tested whether NT-3 could induce NT-3 activated TRPC5 through PLC␥ Activation of TrkC induces the phosphorylation and activation of PLC␥, which plays important roles in TRPC activation (Venkatachalam and Montell, 2007) . To study whether PLC␥ mediated the NT-3-induced [Ca 2ϩ ] i elevation, we used 3-nitrocoumarin, a compound known to inhibit PLC␥ activity without affecting PLC␤ (Perrella et al., 1994; Ward et al., 2002) . As shown in Figure  5 , A and C, 3-NC, but not the inactive analog 7-OH-3-NC, greatly suppressed the NT-3-induced [Ca 2ϩ ] i elevation (3-NC, 0.250 Ϯ 0.083, p ϭ 0.012 vs 7-OH-3-NC). Similarly, NT-4-induced [Ca 2ϩ ] i elevation was also blocked by 3-NC (3-NC, 0.341 Ϯ 0.046, p ϭ 0.004 vs 7-OH-3-NC, Fig. 5 B, C) . These results indicate that PLC␥, via activation of TRPC5 or TRPC6, mediated the effects of NT-3 or NT-4 on [Ca 2ϩ ] i elevation (Figs. 3, 4 , 5A-C). We then asked how TrkC specifically activates TRPC5. We examined whether TrkC was in the complex containing PLC␥ and TRPC5. Immunoprecipitation of the neonatal rat brain lysates using the anti-TrkC antibody revealed that PLC␥1 and TRPC5, but not CaMKII, CaMKI␥, TRPC6, or TRPC3, were found in the precipitated complexes (Fig. 5D) , suggesting that TrkC was specifically associated with TRPC5, but not TRPC6 or TRPC3. Together, these results suggest that NT-3 induced [Ca 2ϩ ] i elevation through the TrkC-PLC␥-TRPC5 pathway.
TRPC5 mediated the effect of NT-3 on dendritic growth
To explore the physiological roles of the Ca 2ϩ influx through TRPC5 activated by NT-3, we examined the effect of NT-3 on dendritic growth in the hippocampal neurons, in which the critical period for dendritic development is after day 4 in culture (Dotti et al., 1988) . We measured the total dendritic tips and total dendritic length to assess the dendritic growth. As shown in Figure 6 , A-E, treatment with NT-3 for 48 h decreased the total dendritic tips and length by 21% ( p ϭ 0.002 vs vehicle) and 36% ( p Ͻ 0.001 vs vehicle), respectively. Knocking down TRPC5 with a vectorbased short hairpin RNA (shTRPC5i) increased the total dendritic tips and length by 21% ( p ϭ 0.020 vs scramble) and 24% ( p ϭ 0.009 vs scramble), and abolished the inhibitory effect of NT-3 on the total dendritic tips ( p ϭ 0.163 vs vehicle) and length ( p ϭ 0.839 vs vehicle). However, knocking down TRPC6 with shTRPC6i decreased the total number of dendritic tips by 20% ( p ϭ 0.017 vs scramble) and total dendritic length by 34% ( p Ͻ 0.001 vs scramble), and did not reverse the inhibitory effect of NT-3 on dendrite growth. In contrast, NT-4 increased both total dendritic tips by ϳ47% and length by ϳ41% ( p ϭ 0.003 for total dendritic tips and p Ͻ 0.001 for total dendritic length vs vehicle, Fig. 6 F-J ) , which is similar to the BDNF effect on dendrite growth. The NT-4-increased dendritic growth was eliminated when the TRPC6 was knocked down ( p ϭ 0.142 for total dendritic tips and p ϭ 0.636 for total dendritic length vs vehicle, Fig. 6G,H ) . These results suggest that TRPC5 mediates the effect of NT-3 on dendritic growth and that TRPC6 mediates the effect of NT-4 on dendritic growth.
NT-3 regulated dendrite growth through the TRPC5-CaMKII␣ pathway
Next we explored how the Ca 2ϩ influx through TRPC5 induced by NT-3 affected dendritic growth. As the Ca 2ϩ effectors, CaMKs are widely involved in Ca 2ϩ signaling. Studies from different groups consistently reported that CaMKII␣ can inhibit dendritic development while CaMKIV can promote dendritic develop- ment (Wu and Cline, 1998; Redmond et al., 2002) . Specifically, CaMKI␥ (Davare et al., 2009) or CaMKII␤ (Puram et al., 2011) was found downstream from TRPC5. To examine whether CaMKs were involved in NT-3 regulation of dendritic growth, we investigated the activity of CaMKI␥, CaMKII␣, CaMKII␤, and CaMKIV in response to NT-3 by detecting the phosphorylation at Thr177 (Fujimoto et al., 2011) , Thr286/287 (Barkai et al., 2000) , or Thr196 (Means, 2000) of the kinases. As shown in Figure 7, A-D , time course experiments revealed that NT-3 increased the phosphorylation of CaMKII␣ and CaMKII␤, but not CaMKI␥ and CaMKIV, whereas NT-4 increased the phosphorylation of CaMKIV, but not CaMKI␥, CaMKII␣, and CaMKII␤. Because the amount of CaMKI␥ is low in young cultures (Davare et al., 2009 ) and because CaMKI␥ promotes dendritic arborization (Wayman et al., 2006; Takemoto-Kimura et al., 2007) , we speculated that CaMKI␥ does not mediate the NT-3-TRPC5 inhibition of dendrite growth. The NT-3-induced phosphorylation of CaMKII was abolished when TRPC5 was knocked down (Fig.  7 E, F ), indicating that TRPC5 was required for the activation of CaMKII induced by NT-3. Moreover, overexpressing TRPC5 did not enhance CaMKII␤ activity, but greatly enhanced CaMKII␣ activity, although downregulating TRPC5 suppressed both CaMKII␣ and CaMKII␤ activity (Fig. 7G,H ) , suggesting that activation of TRPC5 was necessary and sufficient for the activation of CaMKII␣ in the neurons. Because CaMKII␣ is predominantly in the forebrain and CaMKII␤ is predominantly in the cerebellum (McGuinness et al., 1985; Miller and Kennedy, 1985) , and because mRNA of CaMKII␣ is selectively found in dendrites, in contrast to mRNA of CaMKII␤, which is not selectively found in dendrites (Schulman, 2004) , we next examined whether CaMKII␣ was involved in TRPC5 regulation of dendrite development in hippocampal neurons. In the dendrite development assay, overexpressing TRPC5 reduced the number of dendritic tips by 34% and dendritic length by 29% compared with control ( p Ͻ 0.001 vs control). However, expression of a dominantnegative form of CaMKII␣ (Abraham et al., 1997) eliminated the TRPC5 inhibitory effect on dendritic growth (Fig. 7I-M ) . Responding to reports of the possible involvement of L-type voltage-gated Ca 2ϩ channels (L-VGCCs) in NT-3-elevated [Ca 2ϩ ] i (Baldelli et al., 2000; Kang and Schuman, 2000) , we examined whether L-VGCCs played a role in NT-3 inhibition of dendritic growth. However, inhibition of L-VGCCs with nifedipine did not change the NT-3 inhibitory effect on dendritic growth in the neurons (total dendritic length in m: vehicle, 991.90 Ϯ 112.00; 641.80 Ϯ 77.76; nifedipine, 665 .70 Ϯ 60.04; NT-3 plus nifedipine, 508.60 Ϯ 43.65. Data not shown). Together, these results suggest that NT-3 regulated dendritic growth via the TRPC5-CaMKII␣ pathway.
Discussion
In this study, we showed that TRPC5 channels were important for NT-3-induced [Ca 2ϩ ] i elevation and the Ca 2ϩ influx through TRPC5 via activation of CaMKII␣ mediated the inhibitory effect of NT-3 on dendritic growth in the hippocampal neurons. In contrast, Ca 2ϩ influx through TRPC6 was important for NT-4-induced CaMKIV activation and subsequent stimulation of dendritic growth. Our results thus suggest that NT-3 is a physiological activator for TRPC5 channels and that different neurotrophins stimulate distinct signaling modules to activate different channels and the downstream Ca 2ϩ signaling effectors, leading to opposing effects on dendritic development.
TRPC5 activation mechanism
TRPC5, as one of the predominant members of TRPC family expressed in the CNS, plays important roles in axon growth (Greka et al., 2003; Davare et al., 2009) , fear emotion (Riccio et al., 2009) , and neuronal differentiation (Shin et al., 2010) . Although the activation mechanism of TRPC5 has been extensively investigated, the physiological factors that lead to its activation in the CNS remain unidentified. Two endogenous factors reported so far for TRPC5 activation are nitric oxide (NO) in endothelial cells (Yoshida et al., 2006) and reduced thioredoxin in synoviocytes from patients with rheumatoid arthritis (Xu et al., 2008) . Reduced thioredoxin is produced pathologically and endothelial NO is not specifically present in the CNS. Additionally, carbachol (Andrade, 1991) or histamine (Schaefer et al., 2000) , agonists for G q/11 protein-coupled muscarinic or histamine 1 receptors, respectively, were used to activate overexpressed TRPC5 and other TRPCs (Vazquez et al., 2003; Kwon et al., 2007) in cell lines. Meanwhile, reducing extracellular pH (Semtner et al., 2007; Kim et al., 2008) or elevating [Ca 2ϩ ] i (Blair et al., 2009 ) were reported to potentiate the activation of TRPC5 in HEK293 cells. Our results here suggest that NT-3 is a physiological activator for TRPC5 in the CNS. Further, unlike the activation by redox molecules through a direct modification on TRPC5 proteins, the activation for TRPC5 in neurons by NT-3 was through a receptor-operated mechanism. Activation of TrkC by NT-3 leads to the activation of PLC␥, which hydrolyzes PIP 2 into DAG and IP 3 . DAG may modify membrane curvature and stretch, leading to TRPC5 opening (Allan and Michell, 1978; Gomis et al., 2008; Beech et al., 2009) . As TRPC5 channels can be inhibited by PIP 2 (Estacion et al., 2001; del Pilar Gomez and Nasi, 2005; Otsuguro et al., 2008) , it is also possible that PLC␥ releases TRPC5 from inhibition by hydrolyzing PIP 2 , leading to its opening. Further, TRPC5 and TrkC shared the same subcellular localization and TrkC, PLC␥, and TRPC5 were found in the same complex. In contrast, TrkB and TRPC6 shared the same subcellular localization and might coexist in a separate complex. Due to lack of a TrkB antibody able to perform immunoprecipitation, we could not test whether TrkB forms a complex with TRPC6 rather than TRPC5. Collectively, it is likely that subcellular localization and interacting partners play critical roles in the specification of the activation for TRPC5 or TRPC6.
NT-3 induced Ca
2؉ influx in hippocampal neurons It is important to note that in Xenopus spinal neurons, the NT-3-induced [Ca 2ϩ ] i elevation was due to internal Ca 2ϩ release (He et al., 2000; Yang et al., 2001) . Our results here and those of others (Marsh and Palfrey, 1996) suggest that in rat hippocampal neurons, the NT-3-induced [Ca 2ϩ ] i elevation is mainly due to Ca 2ϩ influx. The reason for the difference is not entirely clear, but may stem from the differences in species and cell types. Indeed, in Xenopus motoneurons, NT-3 activates all three classical signaling pathways and potentiates transmitter release (Yang et al., 2001) . However, in the hippocampal slices, NT-3 does not activate MAP (mitogen-activated protein) kinase and PI 3 kinase pathways (Gottschalk et al., 1999) and has no effect on the transmitter release in dentate granule cells (Kokaia et al., 1998) . Thus, it is possible that NT-3 may use the PLC-IP 3 pathway to stimulate IP 3 receptors to release Ca 2ϩ in the motoneurons (Berridge, 1998; He et al., 2000) . However, in the hippocampal neurons, NT-3 may use the PLC-DAG pathway to couple Ca 2ϩ channels, such as TRPs and VGCCs, to induce Ca 2ϩ influx.
The signaling pathway underlying NT-3 regulation on dendrite growth
The roles of NT-3 in cell survival, differentiation, synaptic potentiation, and neuronal morphogenesis have been widely studied. However, the results related to NT-3's role in neuronal morphogenesis have been controversial. Some groups reported that NT-3 promotes neurite growth in neocortex pyramidal neurons (Baker et al., 1998) , cerebellum granule neurons (Ramos et al., 2009) , or inhibitory neurons (Vicario-Abejó n et al., 1998), whereas other studies reported that it inhibits the dendritic growth in other types of neurons (McAllister et al., 1997; Schwyzer et al., 2002; Liu et al., 2009) . In this study, we found that NT-3 inhibited dendritic growth by stimulating the TRPC5-CaMKII␣ pathway in cultured hippocampal neurons. Consistently, CaMKII␣ is involved in the inhibitory regulation of neuronal dendrite development (Wu and Cline, 1998; Redmond et al., 2002) . Moreover, CaMKII␣ is important for the activity-dependent secretion of NT-3 (Kolarow et al., 2007) and the secreted NT-3 in turn induces [Ca 2ϩ ] i elevation and CaMKII␣ activation (He et al., 2000) . It is thus likely that the Ca 2ϩ influx, through TRPC5 induced by NT-3, activates CaMKII␣, and then initiates a signaling cascade to inhibit dendritic development.
A Ying Yang regulation on dendrite growth
One new finding in the current study was that NT-4, one of the ligands of TrkB, promoted dendritic growth through activation of TRPC6. It is possible that NT-4-induced Ca 2ϩ influx through TRPC6 specifically activates CaMKIV and that the activated CaMKIV translocates into the nucleus to activate CREB (Redmond et al., 2002; Tai et al., 2008) and induce gene expression (Shieh et al., 1998) , leading to the promotion effect on dendritic growth (McAllister et al., 1997; Horch et al., 1999) . On the other hand, it is also possible that the Ca 2ϩ influx through TRPC5 induced by NT-3 activates CaMKII␣ and that the activated CaMKII␣ regulates the activity of some small GTPases, which are repressed by CaMKII in the postsynapse (Chen et al., 1998; Li, 2000) , leading to repression of dendritic growth. Collectively, a Ying Yang regulation on neuronal morphogenesis was explored (Fig. 8) . In the CNS, a couple of neurotrophins, NT-3 or NT-4/ BDNF, could respectively activate TRPC5 or TRPC6 via TrkC or TrkB receptors, leading to the specific activation of CaMKII or CaMKIV. The activation of the kinases results in negative or positive regulation of dendrite development, which might be important for the proper development of neuronal dendrites and the formation of correct neuronal circuitry.
